64688-68-2

Basic information

• Product Name: Benzoyl chloride, 2-methyl-5-nitro- (9CI)
• Synonyms: Benzoyl chloride, 2-methyl-5-nitro- (9CI)
• CAS NO: 64688-68-2
• Molecular Formula: C₈H₆ClNO₃
• Molecular Weight: 199.59114
• Product Categories: ACIDHALIDE;Aromatics
• Mol File: 64688-68-2.mol
• Article Data: 32

Chemical Properties

• Melting Point: 52-53°C
• Boiling Point: 110-115°C/0.5
• Appearance: /
• Density: 1.386±0.06 g/cm3(Predicted)
• Stability: Hdrolyzes with Water
• CAS DataBase Reference: Benzoyl chloride, 2-methyl-5-nitro- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoyl chloride, 2-methyl-5-nitro- (9CI)(64688-68-2)
• EPA Substance Registry System: Benzoyl chloride, 2-methyl-5-nitro- (9CI)(64688-68-2)

Safety Data

• Hazardous Substances Data: 64688-68-2(Hazardous Substances Data)

Usage

Chemical Properties

Light Yellow Solid

Uses

2-Methyl-5-nitrobenzoyl Chloride (cas# 64688-68-2) is a compound useful in organic synthesis.

Upstream product

• 939-83-3 2-cyano-4-nitrotoluene 
• 77324-87-9 methyl 2-methyl-5-nitrobenzoate 
• 118-90-1 ortho-methylbenzoic acid 
• 1975-52-6 5-nitro-o-toluic acid 

Downstream Products

• 39272-00-9 (2-methyl-5-nitrophenyl)phenylmethanone 
• 180136-10-1 2-methyl-5-nitro-N-(4-acetoxyphenyl)benzamide 
• 130370-02-4 N,N,2-trimethyl-5-nitrobenzamide 
• 77324-87-9 methyl 2-methyl-5-nitrobenzoate 
• 1554665-03-0 (E)-1-methyl-4-nitro-2-styrylbenzene 
• 58966-27-1 2'-methyl-5'-nitro-acetophenone 
• 781577-11-5 Phe-m-aB-Gly-Gly-Gly-Gly-NHNH₂ 
• 116459-38-2 H-Phe-m-aB-Gly-Gly-Gly-Gly-NHNH₂, 2HCl 
• 116459-39-3 (O₂N) m-aB-Gly-Gly-Gly-Gly-Gly-Gly-Gly-Gly-OEt 
• 116459-37-1 Pht-Phe-m-aB-Gly-Gly-Gly-Gly-OEt 
• 116459-35-9 (O₂N) m-aB-Gly-Gly-Gly-Gly-Gly-Gly-OEt 
• 116459-34-8 (O₂N) m-aB-Gly-Gly-Gly-Gly-OH 
• 116459-32-6 cyclo (Phe-m-aB-Gly-Gly-Gly-Gly) 

Relevant articles and documents

INHIBITORS OF NECROPTOSIS

This invention relates to compounds of Formula (I) and salts, solvates, prodrugs, tautomers, N-oxides, stereoisomers, polymorphs and physiologically functional derivatives thereof. Also disclosed are methods of use of Formula (I), including in the inhibition of necroptosis and treatment of associated diseases, conditions and/or disorders.

BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF

β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.

N-aryl-1-deoxynojirimycin derivative and application thereof in preparing of medicine for treating diabetes

The invention discloses an N-aryl-1-deoxynojirimycin derivative and application thereof in preparing of medicines for treating diabetes. The structural formula of the derivative is as shown in the specification, and in the formula, R1 is halogen or C1-C4 alkyl; R2 is substituted aryl; R3 is H or acyl with 1-4 atoms. The compound disclosed by the invention has functions of remarkably reducing blood sugar and promoting discharge of glucose from urea, and can be used for preparing medicines for treating diabetes.